Join us for a discussion surrounding CMS guideline changes in Parkinsons patient care. Topics will include strategies to keep residents in place, what historical medical data trends show regarding early treatment and long-term wellness, and comparing healthcare resource utilization among medicare beneficiaries treated with Pimavanserin versus other atypical antipsychotics.

ACHCA Members: Complimentary
Non-Members: $125

Register at https://www.achca.org/novwebinar25